Pieters, NL
Eric Pieters, Ak Simpelveld NL
Patent application number | Description | Published |
---|---|---|
20090253866 | SILICONE-POLYMER-MODIFIED VULCANIZED-RUBBER COMPOSITIONS, PROCESSES FOR THEIR PRODUCTION, AND ALSO WINDSHIELD WIPERS ENCOMPASSING SAID MATERIAL - A silicone-polymer-modified vulcanized-rubber composition based on unvulcanized rubber, characterized in that the composition can be produced by co-vulcanization from the following components: | 10-08-2009 |
20100205764 | RUBBER MATERIAL OF A WIPER BLADE FOR WINDSHIELD WIPERS AND PROCESS FOR PRODUCTION THEREOF - A rubber material of a wiper blade for windshield wipers is described, which comprises a first rubber component of a first polarity and a second rubber component of a second greater polarity. To equalize the first and second polarities, the first rubber component is at least partially replaced by a chemically functionalized derivative. | 08-19-2010 |
Eric Pieters, Simpelveld NL
Patent application number | Description | Published |
---|---|---|
20100263156 | WIPER RUBBER FOR WINDSHIELD WIPERS - The invention relates to a wiper rubber for windshield wipers, which contains at least one rubber component that is cured by vulcanization, the material of the wiper rubber containing, at least in the unvulcanized state, a combination of a cross-linking agent with sulfur and/or with a sulfur donor. | 10-21-2010 |
20160002452 | WIPER BLADE ELEMENT - The invention relates to a wiper blade element ( | 01-07-2016 |
20160002459 | WIPER BLADE ELEMENT - The invention relates to a wiper blade element ( | 01-07-2016 |
Henk Pieters, Maastricht NL
Patent application number | Description | Published |
---|---|---|
20080254021 | TIE1-BINDING LIGANDS - Tie1 is a receptor tyrosine kinase protein that includes a transmembrane domain. Tie1 is present on endothelial cells. This disclosure described antibodies that bind to Tie1, including ones that inhibit endothelial cell activity. | 10-16-2008 |
20100196361 | Method of inhibition of vascular development using an antibody - Tie1 and Tie2 are receptor tyrosine kinase proteins that include a transmembrane domain. Tie1 and Tie2 are present on endothelial cells. This disclosure describes agents, such as antibodies, that bind to Tie1, Tie2, and Ang, including ones that inhibit endothelial cell activity and angiogenesis. The agents can be used to treat angiogenesis-associated disorders. | 08-05-2010 |
20100266490 | Metalloproteinase Binding Proteins - Proteins that bind to matrix metalloproteinase 14 and methods of using such proteins are described. | 10-21-2010 |
20110059105 | TIE COMPLEX BINDING PROTEINS - Tie1 and Tie2 are receptor tyrosine kinase proteins that include a transmembrane domain. Tie1 and Tie2 are present on endothelial cells. This disclosure describes agents, such as antibodies, that bind to Tie1, Tie2, and Ang, including ones that inhibit endothelial cell activity. | 03-10-2011 |
20120107231 | METALLOPROTEINASE BINDING PROTEINS - Proteins that bind to matrix metalloproteinase 14 and methods of using such proteins are described. | 05-03-2012 |
Raph Pieters, Bergen NL
Patent application number | Description | Published |
---|---|---|
20160079118 | METHOD OF PROTECTING A MOUNTING TAPE DURING LASER SINGULATION OF A WAFER - A method of singulating a semiconductor wafer with laser energy while the semiconductor wafer is supported on a mounting tape during singulation comprises the step of depositing a coating material onto a portion of the mounting tape adjacent to a perimeter of the semiconductor wafer to form a protective layer over the mounting tape. The semiconductor wafer is then cut with a laser beam such that the laser beam at least partially impinges upon the protective layer during cutting of the semiconductor wafer. After singulation of the semiconductor wafer, the protective layer is removed from the mounting tape. | 03-17-2016 |
Robert Pieters, Rotterdam NL
Patent application number | Description | Published |
---|---|---|
20090004173 | Diagnosis and Treatment of Drug Resistant Leukemia - The present invention encompasses methods and compositions useful in the diagnosis and treatment of drug resistant leukemia. The invention provides a number of genes that are differentially expressed between drug resistant and drug sensitive acute lymphoblastic leukemia (ALL). These genes act as biomarkers for drug resistant leukemia, and further serve as molecular targets for drugs useful in treating drug resistant leukemia. Accordingly, the invention provides methods of diagnosing drug resistant leukemia and methods of selecting a therapy for subjects affected by drug-resistant leukemia. The invention also provides methods for screening for compounds for treating drug-resistant leukemia, and improved methods for treating drug-resistant leukemia. Compositions of the invention include arrays, computer readable media, and kits for use in the methods of the invention. | 01-01-2009 |
Roelof Jan Pieters, Utrecht NL
Patent application number | Description | Published |
---|---|---|
20080312344 | DENDRIMERS MULTIVALENTLY SUBSTITUTED WITH ACTIVE GROUPS - The present invention relates to dendrimers being multivalently substituted with active groups, as well as to processes for the preparation thereof and to the use of such multivalent dendrimers. | 12-18-2008 |
Serge Maria Aloysius Pieters, Ar Hulst NL
Patent application number | Description | Published |
---|---|---|
20140045849 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS - This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as HCV or HBV. | 02-13-2014 |
20140073642 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES - This invention relates to quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy of disorders in which the modulation of toll-like-receptors is involved. | 03-13-2014 |
20150284339 | HETEROCYCLIC SUBSTITUTED 2-AMINO QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS - This invention relates to heterocyclic substituted 2-amino-quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections. | 10-08-2015 |
Serge Maria Aloysius Pieters, Hulst NL
Patent application number | Description | Published |
---|---|---|
20100280025 | EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS - The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENT1 inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENT1 receptors in animals, in particular humans. | 11-04-2010 |
20110281881 | NOVEL SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS GAMMA SECRETASE MODULATORS - The present invention is concerned with substituted bicyclic heterocyclic compounds of Formula (I) | 11-17-2011 |
20120095036 | NOVEL SUBSTITUTED INDAZOLE AND AZA-INDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS - The present invention is concerned with novel substituted indazole and aza-indazole derivatives of Formula (I) | 04-19-2012 |
20120135981 | NOVEL SUBSTITUTED TRIAZOLE AND IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS - The present invention is concerned with novel substituted triazole and imidazole derivatives of Formula (I) | 05-31-2012 |
20150239892 | Pyrrolo[3,2-]pyrimidine derivatives for the treatment of viral infections and other diseases - This invention concerns pyrrolo[3,2-d]pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treatment and/or therapy of diseases. | 08-27-2015 |
Serge Marie Aloysius Pieters, Hulst NL
Patent application number | Description | Published |
---|---|---|
20150274676 | ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES - This invention relates to acylaminopyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy. | 10-01-2015 |